## EFX: Equifax, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.3% below STRENGTH zone (3.0-6.0%); PEG 1.05 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($200.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Equifax (NYSE:EFX) Shares Little Changed in Data Sector Focus**
- Source: Kalkine Media | 20251208T183629 | Neutral | Relevance: 99%
-  Equifax (NYSE:EFX) shares remained largely unchanged as the market focused on the data sector. The article provides an overview of Equifax's global operations, emphasizing its secure, accurate, and compliant data verification, consumer and commercial data solutions, and technological services within the S&P 500 Index sector. The company highlights its commitment to data accuracy through quality assurance, system monitoring, automated verification, encryption, and regulatory compliance.

**2. WINTON GROUP Ltd Makes New Investment in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251208T130808 | Somewhat-Bullish | Relevance: 99%
-  WINTON GROUP Ltd recently acquired a new stake of 17,623 shares in Equifax for approximately $4.57 million, contributing to institutional ownership exceeding 96%. Equifax outperformed Q3 estimates with $2.04 EPS and $1.54 billion revenue, while setting optimistic guidance for Q4 and FY2025. Despite recent insider selling, the company announced a quarterly dividend of $0.50 per share.

**3. Marshall Wace LLP Makes New Investment in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251209T121121 | Neutral | Relevance: 99%
-  Marshall Wace LLP has made a new investment in Equifax, Inc. (NYSE:EFX), acquiring 84,383 shares valued at approximately $21.9 million. Other institutional investors like Price T Rowe Associates Inc. MD and Norges Bank also adjusted their holdings, resulting in 96.20% of EFX being owned by institutional investors and hedge funds. Despite significant institutional buying, insiders have been net sellers, offloading 54,270 shares worth about $12.6 million in the past 90 days.

**4. iSAM Funds UK Ltd Buys Shares of 9,678 Equifax, Inc. $EFX**
- Source: MarketBeat | 20251209T140758 | Neutral | Relevance: 98%
-  iSAM Funds UK Ltd acquired 9,678 shares of Equifax, Inc. (NYSE:EFX) in the second quarter, valued at approximately $2.51 million, as disclosed in its recent 13F filing. Other institutional investors have also adjusted their holdings in Equifax, which currently has a "Moderate Buy" consensus rating from Wall Street analysts. The company recently announced a quarterly dividend of $0.50 per share.

**5. Amundi Buys 23,161 Shares of Equifax, Inc. $EFX**
- Source: MarketBeat | 20251209T080808 | Neutral | Relevance: 98%
- Amundi has increased its stake in Equifax, Inc. (NYSE:EFX) by 11.2%, acquiring an additional 23,161 shares, bringing its total holdings to 230,283 shares valued at approximately $60.4 million. Several other institutional investors also adjusted their positions in the credit services provider during the second quarter. Meanwhile, company insiders, including CEO Mark W. Begor and EVP Jamil Farshchi, sold a significant number of shares, while Wall Street analysts provided a "Moderate Buy" consensus rating with a target price of $276.40.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 13.6% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.9B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 23.8 |
| Current P/E | 27.6 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.9% to -1.3% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.3pp (needs >3.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. MACD histogram positive (1.13), confirming momentum. RSI neutral at 45.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.28% (CS: 42) | Neutral |
| RSI_14 | 45.0 | Neutral |
| MACD Histogram | 1.13 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.954x | Below |
| vs SMA200 | 0.864x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $210.29
- **Stop Loss:** $200.27 (4.8% risk)
- **Target:** $220.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 49
- **Position Value:** $10,304.21
- **Portfolio %:** 10.30%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*